Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-03-22 Audit Report / Informat…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB_SA_Report_KAM NL.pdf
Audit Report / Information Classification · 1% confidence The document is a 'Verslag van de commissaris' (Auditor's Report) for UCB NV for the fiscal year ending December 31, 2023. It details the auditor's opinion on the financial statements, key audit matters, and responsibilities of the board and the auditor. It is a standalone audit report, not the full annual report itself, fitting the definition for 'Audit Report / Information'. FY 2023
2024-03-22 Dutch
UCB SA_Board of Directors report_12_2023 NL - Final (web).pdf
Audit Report / Information Classification · 1% confidence The document is titled 'Jaarverslag van de Raad van Bestuur' (Annual Report of the Board of Directors) for UCB NV for the fiscal year ending December 31, 2023. It contains detailed financial results, balance sheet analysis, dividend proposals, and management commentary on business activities. While it references a separate 'Integrated Annual Report' for consolidated group data, this specific document serves as the statutory annual report for the parent company (UCB NV) as required by law. It is not an announcement (RPA) but the report itself. FY 2023
2024-03-22 Dutch
ENG - Convening notice AEGM April 2024 - Final.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS" and details the agenda items for an upcoming meeting scheduled for April 25, 2024. The agenda includes voting on annual accounts, remuneration reports, director appointments/renewals, and auditor mandates. This content is characteristic of materials prepared for a shareholder meeting, specifically a notice convening that meeting. The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. While it is a convening notice rather than the presentation itself, it is the primary document related to the AGM proceedings.
2024-03-22 English
FR - Convocation AEGM avril 2024 - Final.pdf
AGM Information Classification · 1% confidence The document is explicitly titled 'CONVOCATION A L'ASSEMBLEE GENERALE DES ACTIONNAIRES' (Notice of the General Shareholders' Meeting) and details the agenda for a meeting scheduled for April 25, 2024. The agenda items cover the approval of annual accounts, remuneration reports, appointment/re-appointment of directors, and the auditor. This content is the official notice and materials presented to shareholders for voting at the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). It is not a full 10-K, an Earnings Release (ER), or a proxy statement (PSI), but the formal notice convening the meeting itself.
2024-03-22 French
NL - Convening notice AGM April 2024 - Final.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "OPROEPING TOT DE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Notice of the General Meeting of Shareholders) and details the agenda items to be discussed and voted upon at a meeting scheduled for April 25, 2024. The agenda includes the approval of the annual accounts, remuneration report, appointment/reappointment of directors, and renewal of the auditor's mandate. This content structure is characteristic of materials prepared for an Annual General Meeting (AGM). Although it covers annual financial results (related to the 10-K period), the primary purpose and format are that of the meeting notice/materials, which aligns best with the AGM-R code.
2024-03-22 Dutch
UCB-IntegratedAnnualRpt-EN-23 Final V3.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'Integrated Annual Report 2023' and contains comprehensive sections including a letter to stakeholders, business performance reviews, corporate governance statements, remuneration reports, and consolidated financial statements with auditor reports. It meets the criteria for a full annual report (10-K equivalent for this jurisdiction) rather than a summary or announcement. FY 2023
2024-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.